2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Reporting of observational studies explicitly aiming to emulate randomized trials: a systematic review
Importance Observational (nonexperimental) studies that aim to emulate a randomized trial
(ie, the target trial) are increasingly informing medical and policy decision-making, but it is …
(ie, the target trial) are increasingly informing medical and policy decision-making, but it is …
Management of acute coronary syndrome in the older adult population: a scientific statement from the American Heart Association
Diagnostic and therapeutic advances during the past decades have substantially improved
health outcomes for patients with acute coronary syndrome. Both age-related physiological …
health outcomes for patients with acute coronary syndrome. Both age-related physiological …
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
Multiple guidelines and consensus papers have addressed the role of antithrombotic
strategies in patients with established coronary artery disease (CAD). Since evidence and …
strategies in patients with established coronary artery disease (CAD). Since evidence and …
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
The first international guidance on antithrombotic therapy in the elderly came from the
European Society of Cardiology Working Group on Thrombosis in 2015. This same group …
European Society of Cardiology Working Group on Thrombosis in 2015. This same group …
[HTML][HTML] Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond
Y Saito, K Oyama, K Tsujita, S Yasuda, Y Kobayashi - Journal of cardiology, 2023 - Elsevier
Owing to recent advances in early reperfusion strategies, pharmacological therapy,
standardized care, and the identification of vulnerable patient subsets, the prognosis of …
standardized care, and the identification of vulnerable patient subsets, the prognosis of …
Management of acute coronary syndromes in older adults
Older patients are underrepresented in prospective studies and randomized clinical trials of
acute coronary syndromes (ACS). Over the last decade, a few specific trials have been …
acute coronary syndromes (ACS). Over the last decade, a few specific trials have been …
Acute coronary syndrome in the older patient
S Garcia-Blas, A Cordero, P Diez-Villanueva… - Journal of Clinical …, 2021 - mdpi.com
Coronary artery disease is one of the leading causes of morbidity and mortality, and its
prevalence increases with age. The growing number of older patients and their differential …
prevalence increases with age. The growing number of older patients and their differential …
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations
Introduction Clopidogrel is the most frequently utilized P2Y12 inhibitor and is characterized
by broad interindividual response variability resulting in impaired platelet inhibition and …
by broad interindividual response variability resulting in impaired platelet inhibition and …
Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis
Importance The optimal duration of dual antiplatelet therapy (DAPT) for older adults after
percutaneous coronary intervention (PCI) is uncertain because they are simultaneously at …
percutaneous coronary intervention (PCI) is uncertain because they are simultaneously at …